An Injectable Electroactive Hydrogel Engineered for Stable Bioelectronic Interfaces
Advanced Materials Interfaces · 2026-07 · 13 (13)
DOI: 10.1002/admi.70566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials Interfaces, online erschienen am 10.06.2026. Verfasst von Ying Zhou und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Wollongong, Australian National Fabrication Facility, Cancer Institute NSW.
Abstract (Originalsprache)
Electroceutical therapies are fundamentally limited by the electrode–tissue interface: achieving long‐term, low‐impedance electrical coupling while maintaining mechanical compliance, and intimate tissue contact in wet environments. Minimally invasive deployment remains a persistent challenge. Injectable conductive hydrogels provide a promising strategy by enabling in situ formation of soft, conformal, and bioactive interfaces within complex and irregular tissues. Here we present an injectable, wet‐adhesive, and electroconductive hydrogel platform composed of catechol‐modified hyaluronic acid, alginate, and edge‐functionalized graphene (EFG). The pre gel display pronounced shear‐thinning and rapid self‐recovery, supporting catheter‐compatible delivery and spatial localization after injection. A dual ionic and oxidative crosslinking mechanism decouples gelation kinetics from bulk mechanical properties and tissue‐gel interfacial adhesion, yielding a tissue‐matched interface that resists delamination under physiological conditions. Incorporation of EFG adds electrical conductivity and charge injection capacity, providing electrochemical functionality relevant to stimulation. The hydrogel maintains stable mechanical and conductive performance and supports the viability of human neural cells in vitro. Ex vivo studies in porcine brain tissue demonstrate intimate conformity and integration, while four‐month subcutaneous implantation in sheep confirms favorable in vivo biocompatibility without adverse inflammatory responses. Collectively, this work establishes an injectable conductive hydrogel platform for stable, flexible, and electrochemically active bioelectronic interfaces.
Förderung
- University of Wollongong
- Australian National Fabrication Facility
- Cancer Institute NSW
- National Health and Medical Research Council
- Centre of Excellence for Electromaterials Science, Australian Research Council
- Garnett Passe and Rodney Williams Memorial Foundation
Zitieren
APA
Zhou, Y., Zheng, P., Cheung, B., Huang, C. Y., Ryder, G., Clark, J. R., Maruf, D. S. A. A., Wu, Y., Ker, M., Huang, X., Wallace, G. G., & Liu, X. (2026). An Injectable Electroactive Hydrogel Engineered for Stable Bioelectronic Interfaces. Advanced Materials Interfaces, 13(13). https://doi.org/10.1002/admi.70566
Vancouver
Zhou Y, Zheng P, Cheung B, Huang CY, Ryder G, Clark JR, et al. An Injectable Electroactive Hydrogel Engineered for Stable Bioelectronic Interfaces. Advanced Materials Interfaces. 2026;13(13). doi:10.1002/admi.70566
BibTeX
@article{Zhou2026,
author = {Zhou, Ying and Zheng, Peng and Cheung, Beverley and Huang, Chien Yu and Ryder, Greg and Clark, Jonathan R and Maruf, D S Abdullah Al and Wu, Yi‐Hui and Ker, Ming‐Dou and Huang, Xufeng and Wallace, Gordon G and Liu, Xiao},
title = {An Injectable Electroactive Hydrogel Engineered for Stable Bioelectronic Interfaces},
journal = {Advanced Materials Interfaces},
year = {2026},
volume = {13},
number = {13},
doi = {10.1002/admi.70566}
}
EUVIMED